Stephen Gallagher Email & Phone Number | Vice President, Finance

Stephen Gallagher

Vice President, Finance - Commercial
New York, New York, United States

*50 free lookup(s) per month.

No credit card required.

Stephen Gallagher’s Email sgallagher@intracellulartherapies.com

Stephen Gallagher’s Phone Numbers +1 212-923-****

Get STEPHEN’s Phone Number (For Free)

Social Media

Stephen Gallagher’s Location New York, New York, United States

Stephen Gallagher’s Current Industry Intra-Cellular Therapies

Not the Stephen Gallagher you were looking for?

Find accurate emails & phone numbers for over 700M professionals.

Work Experience

Intra-Cellular Therapies

Vice President Finance - Commercial

2020-04-01 - Present

Perrigo

VP CFO, Rx Pharmaceuticals

2013-04-01 - 2018-12-01

Actavis

VP Finance

2009-02-01 - 2013-03-01

Glenmark Pharmaceuticals

VP Finance & Treasurer

2008-01-01 - 2008-11-01

Pliva, Inc

Acting CFO/Sr. Director Finance & Controller

2005-03-01 - 2008-01-01

GlaxoSmithKline (Block Drug Company)

VP Controller Americas Division

2000-04-01 - 2003-01-01

GlaxoSmithKline(Block Drug Company)

SAP Team Lead &Configuration Support Manager

1998-03-01 - 2000-06-01

Skills

biotechnology life sciences neuropsychiatric & neurodegenerative diseases biopharmaceuticals central nervous system disorders schizophrenia research & development drug product development bipolar disorder major depressive disorder parkinsons disease

Languages

FAQ About Stephen Gallagher

Stephen Gallagher is located at
New York, New York, United States

Stephen Gallagher is a Vice President, Finance - Commercial

Stephen Gallagher currently works in the Intra-Cellular Therapies |

Stephen Gallagher speaks the following languages: English

Stephen Gallagher has prior
experience in the following industries:
Perrigo | Actavis | Glenmark Pharmaceuticals | Pliva, Inc | GlaxoSmithKline (Block Drug Company) | GlaxoSmithKline(Block Drug Company)

Stephen Gallagher has the following professional experience:
Intra-Cellular Therapies | Perrigo | Actavis | Glenmark Pharmaceuticals | Pliva, Inc | GlaxoSmithKline (Block Drug Company) | GlaxoSmithKline(Block Drug Company)